{"count": 4, "results": [{"_id": "32829010", "pmid": 32829010, "title": "Repurposing metformin, simvastatin and digoxin as a combination for targeted therapy for pancreatic ductal adenocarcinoma.", "journal": "Cancer Lett", "authors": ["Liu SH", "Yu J", "Creeden JF", "Sutton JM", "Markowiak S", "Sanchez R", "Nemunaitis J", "Kalinoski A", "Zhang JT", "Damoiseaux R", "Erhardt P", "Brunicardi FC"], "date": "2020-10-28T00:00:00Z", "doi": "10.1016/j.canlet.2020.08.002", "meta_date_publication": "2020 Oct 28", "meta_volume": "491", "meta_issue": "", "meta_pages": "97-107", "score": 50266.29, "text_hl": "Repurposing @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@ and @CHEMICAL_Digoxin @CHEMICAL_MESH:D004077 @@@digoxin@@@ as a combination for targeted therapy for @<m>DISEASE_Carcinoma_Pancreatic_Ductal</m> @DISEASE_MESH:D021441 @@@pancreatic ductal adenocarcinoma@@@.", "citations": {"NLM": "Liu SH, Yu J, Creeden JF, Sutton JM, Markowiak S, Sanchez R, Nemunaitis J, Kalinoski A, Zhang JT, Damoiseaux R, Erhardt P, Brunicardi FC. Repurposing metformin, simvastatin and digoxin as a combination for targeted therapy for pancreatic ductal adenocarcinoma. Cancer Lett. 2020 Oct 28;491():97-107. PMID: 32829010", "BibTeX": "@article{32829010, title={Repurposing metformin, simvastatin and digoxin as a combination for targeted therapy for pancreatic ductal adenocarcinoma.}, author={Liu SH and Yu J and Creeden JF and Sutton JM and Markowiak S and Sanchez R and Nemunaitis J and Kalinoski A and Zhang JT and Damoiseaux R and Erhardt P and Brunicardi FC}, journal={Cancer Lett}, volume={491}, pages={97-107}}"}}, {"_id": "37752238", "pmid": 37752238, "pmcid": "PMC10522691", "title": "Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice", "journal": "Sci Rep", "authors": ["Teper Y", "Ye L", "Waldron RT", "Lugea A", "Sun X", "Sinnett-Smith J", "Hines OJ", "Pandol SJ", "Rozengurt E", "Eibl G"], "date": "2023-09-26T00:00:00Z", "doi": "10.1038/s41598-023-43498-9", "meta_date_publication": "2023 Sep 26", "meta_volume": "13", "meta_issue": "1", "meta_pages": "16144", "score": 50260.824, "text_hl": "Here, four-week-old @SPECIES_10090 @@@mice@@@ expressing KrasG12D in all pancreatic lineages (KC @SPECIES_10090 @@@mice@@@) and fed an obesogenic high fat, high calorie diet that promotes early @<m>DISEASE_Carcinoma_Pancreatic_Ductal</m> @DISEASE_MESH:D021441 @@@PDAC@@@ development were randomized onto low dosage @CHEMICAL_Metformin @CHEMICAL_MESH:D008687 @@@metformin@@@, @<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@simvastatin@@@, or both drugs in combination administered orally. ", "citations": {"NLM": "Teper Y, Ye L, Waldron RT, Lugea A, Sun X, Sinnett-Smith J, Hines OJ, Pandol SJ, Rozengurt E, Eibl G. Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice Sci Rep. 2023 Sep 26;13(1):16144. PMID: 37752238", "BibTeX": "@article{37752238, title={Low dosage combination treatment with metformin and simvastatin inhibits obesity-promoted pancreatic cancer development in male KrasG12D mice}, author={Teper Y and Ye L and Waldron RT and Lugea A and Sun X and Sinnett-Smith J and Hines OJ and Pandol SJ and Rozengurt E and Eibl G}, journal={Sci Rep}, volume={13}, number={1}, pages={16144}}"}}, {"_id": "35599097", "pmid": 35599097, "title": "Corrigendum to \"Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-beta1/Gfi-1\" [Canc. Lett. 385 (2017) 65-74].", "journal": "Cancer Lett", "authors": ["Xian G", "Zhao J", "Qin C", "Zhang Z", "Lin Y", "Su Z"], "date": "2022-08-01T00:00:00Z", "doi": "10.1016/j.canlet.2022.215739", "meta_date_publication": "2022 Aug 1", "meta_volume": "540", "meta_issue": "", "meta_pages": "215739", "score": 50249.066, "text_hl": "Corrigendum to \"@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ attenuates macrophage-mediated @CHEMICAL_Gemcitabine @CHEMICAL_MESH:D000093542 @@@gemcitabine@@@ resistance of @<m>DISEASE_Carcinoma_Pancreatic_Ductal</m> @DISEASE_MESH:D021441 @@@pancreatic ductal adenocarcinoma@@@ by regulating the @GENE_TGFB1 @GENE_7040 @@@TGF-beta1@@@/@GENE_GFI1 @GENE_2672 @@@Gfi-1@@@\" [Canc. ", "citations": {"NLM": "Xian G, Zhao J, Qin C, Zhang Z, Lin Y, Su Z. Corrigendum to \"Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-beta1/Gfi-1\" [Canc. Lett. 385 (2017) 65-74]. Cancer Lett. 2022 Aug 1;540():215739. PMID: 35599097", "BibTeX": "@article{35599097, title={Corrigendum to \"Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-beta1/Gfi-1\" [Canc. Lett. 385 (2017) 65-74].}, author={Xian G and Zhao J and Qin C and Zhang Z and Lin Y and Su Z}, journal={Cancer Lett}, volume={540}, pages={215739}}"}}, {"_id": "27840243", "pmid": 27840243, "title": "Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-beta1/Gfi-1 axis.", "journal": "Cancer Lett", "authors": ["Xian G", "Zhao J", "Qin C", "Zhang Z", "Lin Y", "Su Z"], "date": "2017-01-28T00:00:00Z", "doi": "10.1016/j.canlet.2016.11.006", "meta_date_publication": "2017 Jan 28", "meta_volume": "385", "meta_issue": "", "meta_pages": "65-74", "score": 50062.625, "text_hl": "@<m>CHEMICAL_Simvastatin</m> @CHEMICAL_MESH:D019821 @@@Simvastatin@@@ attenuates macrophage-mediated @CHEMICAL_Gemcitabine @CHEMICAL_MESH:D000093542 @@@gemcitabine@@@ resistance of @<m>DISEASE_Carcinoma_Pancreatic_Ductal</m> @DISEASE_MESH:D021441 @@@pancreatic ductal adenocarcinoma@@@ by regulating the @GENE_TGFB1 @GENE_7040 @@@TGF-beta1@@@/@GENE_GFI1 @GENE_2672 @@@Gfi-1@@@ axis.", "citations": {"NLM": "Xian G, Zhao J, Qin C, Zhang Z, Lin Y, Su Z. Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-beta1/Gfi-1 axis. Cancer Lett. 2017 Jan 28;385():65-74. PMID: 27840243", "BibTeX": "@article{27840243, title={Simvastatin attenuates macrophage-mediated gemcitabine resistance of pancreatic ductal adenocarcinoma by regulating the TGF-beta1/Gfi-1 axis.}, author={Xian G and Zhao J and Qin C and Zhang Z and Lin Y and Su Z}, journal={Cancer Lett}, volume={385}, pages={65-74}}"}}]}